|
Form Serial Number: |
DA20231229E00291
|
1.
Date of relevant event: |
27/10/2023 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
06855 |
4.
Name of listed corporation: |
Ascentage Pharma Group International - B |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
289,846,771 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Yang |
(Other names) |
Dajun |
|
|
|
10.
Name of director (Chinese): |
楊大俊 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1213 | The number of shares in which you are interested has reduced because: any other event (you must briefly describe the relevant event in the Supplementary Information box) | |
|
|
12,026 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 64,617,035 | 22.29 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 64,585,929 | 22.28 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
| |
2202 | Interest of your spouse |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| | | | | | | | | 0 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
Spouse | Zhai Yifan | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Ascentage Limited | Woodbourne Hall, P.O. Box 3162, Road Town, Tortola, British Virgin Islands | Yang Dajun | 45.53 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
Ascentage Limited | Addresses of individuals are not displayed. | |
HealthQuest Pharma Limited | Addresses of individuals are not displayed. | |
Zhai Yifan | Addresses of individuals are not displayed. | |
Guo Edward Ming | Addresses of individuals are not displayed. | |
Wang Shaomeng | Addresses of individuals are not displayed. | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
Dajun Yang Dynasty Trust | Addresses of individuals are not displayed. | 5103 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Dajun Yang held his interests in box 26 as beneficial owner, jointly with other persons, as a spouse, through interests in controlled corporation and as founder of a trust. Shares has been vested to Ms. Zha,i, spouse of Mr. Yang, under 2018 RSU Scheme and 126,000 shares has been deliver to her on the date of relevant event. After deduction of 31,106 shares, 94,984 shares has been deposited.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
29/12/2023 (dd/mm/yyyy)
|
|